EGB Capital

Funding rounds backed by EGB Capital.

Export CSV
Funding disclosed in full
$14.4M
Median round
$14.4M
Rounds in calculation
1
Funding rounds with company descriptions, amounts, stages and announcement dates
CompanyRoundMarketInvestorsAnnouncedDetails
Syntax Bio

Develops cell therapies using proprietary Cellgorithm platform for regenerative medicine

$14.4MSeries A+BiotechUnited States
16 participantsAllegis CapitalAstellas Venture ManagementCivilization VenturesDCVC BioDraper AssociatesEGB CapitalExit FundIllinois VenturesIllumina VenturesLongGameMansueto OfficeMayo ClinicPortal InnovationsSigma Groupthe Illinois Department of Commerce and Economic OpportunityWalder Ventures